19-53258511-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173856.2(VN1R2):āc.136A>Gā(p.Thr46Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,402,806 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173856.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VN1R2 | NM_173856.2 | c.136A>G | p.Thr46Ala | missense_variant | 1/1 | ENST00000341702.3 | NP_776255.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VN1R2 | ENST00000341702.3 | c.136A>G | p.Thr46Ala | missense_variant | 1/1 | NM_173856.2 | ENSP00000351244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000487 AC: 74AN: 151994Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000373 AC: 58AN: 155412Hom.: 0 AF XY: 0.000341 AC XY: 28AN XY: 82124
GnomAD4 exome AF: 0.000241 AC: 301AN: 1250694Hom.: 5 Cov.: 19 AF XY: 0.000260 AC XY: 162AN XY: 624066
GnomAD4 genome AF: 0.000473 AC: 72AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000444 AC XY: 33AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.136A>G (p.T46A) alteration is located in exon 1 (coding exon 1) of the VN1R2 gene. This alteration results from a A to G substitution at nucleotide position 136, causing the threonine (T) at amino acid position 46 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at